Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Myung-Ju Ahn

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered With PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer

English

Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and Its Clinical Implication

Journal of Thoracic Oncology

English

First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results From a Randomized Phase 3 Study

Journal of Thoracic Oncology

English

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK

Journal of Thoracic Oncology

English

Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

Journal of Thoracic Oncology

English

Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC

Journal of Thoracic Oncology

English

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-mutated Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Clinical Trial of Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck: A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)

English

Pazopanib Maintenance After First-Line Etoposide and Platinum Chemotherapy in Patients With Extensive Disease Small-Cell Lung Cancer: A Multicentre, Randomised, Placebo-Controlled Phase II Study (KCSG-LU12-07)

British Journal of Cancer

Cancer Research

Oncology

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Myung-Ju Ahn

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered With PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer

Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and Its Clinical Implication

First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results From a Randomized Phase 3 Study

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK

Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-mutated Advanced Non-Small Cell Lung Cancer

Clinical Trial of Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck: A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)

Pazopanib Maintenance After First-Line Etoposide and Platinum Chemotherapy in Patients With Extensive Disease Small-Cell Lung Cancer: A Multicentre, Randomised, Placebo-Controlled Phase II Study (KCSG-LU12-07)